A House Republican plan to tackle drug shortages focuses on increased reimbursement to shore up the US supply chain, relying on manufacturer’s good will rather than mandates to use those additional resources to prevent and mitigate drug shortages.
Key Takeaways
-
Financial perks in Medicaid, 340b and Medicare for drugs at risk of shortages (mostly generics) would be awarded under a new Republican plan.
-
Experts...
The bill’s failure to extract supply chain commitments from drug companies or other health care entities in exchange for new government funding is unlikely to lead to the enhanced drug...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?